375 results
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
12 Mar 24
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
4:10pm
commitments;
we exclude restructuring expenses from adjusted EBITDA. Restructuring expenses primarily include employee severance and contract termination … clinical and manufacturing liabilities
Accrued payroll and employee liabilities
Other accrued liabilities
Current lease liabilities
Total current
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
14 Nov 23
Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
4:10pm
clinical and manufacturing liabilities
Accrued payroll and employee liabilities
Other accrued liabilities
Current lease liabilities
Total current
424B3
ykfohc
5 Sep 23
Prospectus supplement
9:14pm
8-K
EX-99.1
wmgi9jz
14 Aug 23
Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates
4:11pm
8-K
EX-10.1
aye8fyinmu8e6
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
8-K
EX-99.2
xjibhvk4bee
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
S-8
ye306c
30 Jun 23
Registration of securities for employees
4:06pm
S-8
EX-5.1
qgeap 9t7qnejgdsk
30 Jun 23
Registration of securities for employees
4:06pm
S-8
qrvhg7gjcl6kigrobvu
30 Jun 23
Registration of securities for employees
4:06pm
S-8
EX-99.2
ul0eg24
30 Jun 23
Registration of securities for employees
4:06pm